Literature DB >> 4284247

Apnea during treatment with sodium colistimethate.

A F Parisi, M H Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4284247

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

2.  Colistimethate as a cause of postoperative apnoea.

Authors:  H L Zauder; N Barton; E J Bennett; J Lore
Journal:  Can Anaesth Soc J       Date:  1966-11

Review 3.  Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  Daniel Conole; Gillian M Keating
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

4.  Myopathy caused by polymyxin E: functional disorder of the cell membrane.

Authors:  M Vanhaeverbeek; M Ectors; L Vanhaelst; L Franken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-12       Impact factor: 10.154

5.  Renal and neurological side effects of colistin in critically ill patients.

Authors:  Herbert Spapen; Rita Jacobs; Viola Van Gorp; Joris Troubleyn; Patrick M Honoré
Journal:  Ann Intensive Care       Date:  2011-05-25       Impact factor: 6.925

Review 6.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Intravenous colistin-induced acute respiratory failure: A case report and a review of literature.

Authors:  Amardeep Shrestha; Sheryll Mae Soriano; Mingchen Song; Shingo Chihara
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.